新广益的保荐机构（主承销商）是中信证券股份有限公司，保荐代表人是李锐、王嘉宇。这是中信 证券今年保荐成功的第5单IPO项目。此前，2月21日，中信证券保荐的江苏汉邦科技股份有限公司过 会；4月18日，中信证券保荐的广州瑞立科密汽车电子股份有限公司过会；7月11日，中信证券保荐的北 矿检测技术股份有限公司过会；8月14日，中信证券保荐的西安奕斯伟材料科技股份有限公司过会。 新广益是一家专注于高性能特种功能材料研发、生产及销售的高新技术企业，主要产品有抗溢胶特 种膜、强耐受性特种膜等特种功能材料。 中国经济网北京9月20日讯 深圳证券交易所上市审核委员会2025年第20次审议会议于昨日召开，审 议结果显示，苏州市新广益电子股份有限公司（以下简称"新广益"）符合发行条件、上市条件和信息披 露要求。这是今年过会的第52家企业（其中，上交所和深交所一共过会30家，北交所过会22家）。 无 2025年上交所深交所IPO过会企业一览： | 序号 | 公司名称 | 上会日期 | 拟上市地点 | 保荐机构 | | --- | --- | --- | --- | --- | | 1 | 马可波罗控股股份有限 | 2025/1/1 ...

Core Viewpoint - Suzhou Xinguangyi Electronic Co., Ltd. has successfully passed the IPO review, focusing on high-performance specialty functional materials [1][3]. Company Overview - Xinguangyi specializes in the R&D, production, and sales of high-performance specialty functional materials, with key products including anti-overflow special films and strong resistance special films [3]. - The anti-overflow special film is crucial in the production process of flexible circuit boards, serving multiple functions such as anti-overflow, release, wrinkle resistance, and protection [3]. - The strong resistance special film is designed for extreme production environments, used in automated production processes of flexible and printed circuit boards, providing protection, traction, support, and fixation [3]. - Since its establishment in 2004, Xinguangyi has broken the technological monopoly of companies from Japan, the US, and Europe in its product categories, becoming the market leader in China [3]. Financial Performance - From 2022 to 2024, Xinguangyi achieved revenues of 455 million yuan, 516 million yuan, and 657 million yuan, with net profits of 82 million yuan, 83 million yuan, and 116 million yuan respectively [4]. - In the first half of 2025, the company reported revenues of 313 million yuan, a year-on-year increase of 10.24%, and a net profit of 59 million yuan, up 17.45% year-on-year [4]. - The growth in demand from major clients in the consumer electronics and new energy vehicle sectors has positively impacted Xinguangyi's performance [4]. IPO and Future Plans - Xinguangyi plans to raise 638 million yuan through its IPO, which will be invested in functional material projects to enhance product technology, deepen core competitive advantages, and improve delivery capabilities [4]. - This funding is expected to support the company's continuous revenue growth and help maintain its leading position in the industry [4].

Group 1 - The core business of the company is focused on the research, development, production, and sales of high-performance specialty functional materials, including anti-bleed specialty films and high-resistance specialty films [2] - The company achieved revenues of 455 million yuan, 516 million yuan, and 657 million yuan for the years 2022, 2023, and 2024 respectively, with net profits of 81.51 million yuan, 83.28 million yuan, and 116 million yuan during the same period [2][3] - As of the end of the reporting period, the total assets of the company were 836.05 million yuan, with a total equity attributable to the parent company of 678.76 million yuan, and a debt-to-asset ratio of 18.95% [3] Group 2 - The company has a strong focus on research and development, with R&D expenses accounting for 4.72% of operating revenue in 2024 [3] - The company’s major shareholders, Xia Chaohua and Xia Huachao, collectively control 85.54% of the voting rights [3] - The company has a history of cash dividends, with a distribution of 220 million yuan from undistributed profits approved by shareholders in November 2021 [5] Group 3 - The company’s board of directors includes key figures such as Xia Chaohua as Chairman and Li Yongsheng as General Manager, with their terms running from February 2025 to February 2028 [5] - Xia Chaohua has extensive experience in various roles within the company since its inception, contributing to its strategic direction and operational management [8][9] - Xia Huachao has also held multiple positions in different companies, indicating a strong background in business management [10]

Group 1 - The core viewpoint of the article is that Suzhou Xinguangyi Electronic Co., Ltd. is about to undergo a significant review by the Shenzhen Stock Exchange after being in the inquiry phase for over two years [1] - Xinguangyi specializes in the research, production, and sales of high-performance special functional materials, with its main products being anti-bleeding special films and strong resistance special films [2] - The company claims to be the domestic leader in the anti-bleeding special film segment, holding the largest market share in China [2] Group 2 - The company plans to raise 638 million yuan for the construction of functional material projects, which will produce products such as high-end TPX anti-bleeding special films and acoustic films [2] - From 2022 to 2024, the company's main business revenue is projected to grow from 455 million yuan to 657 million yuan, with net profits increasing from approximately 81.51 million yuan to 116 million yuan [4] - In the first half of 2025, the company reported revenue of 313 million yuan, a year-on-year increase of 10.24% [4] Group 3 - Despite revenue and profit growth, the company's gross margin has been under pressure, declining from 38.74% in 2020 to 31.76% in 2022, a drop of about 7 percentage points [5] - The company's gross margin has remained around 31% to 32% during the reporting period, indicating it has not yet recovered to the 2020 levels [6][7] - The company acknowledges that if raw material prices rise significantly and it cannot pass on costs to customers, its gross margin may decline further [7] Group 4 - The average selling price of the company's anti-bleeding special films and strong resistance special films has shown a downward trend, particularly with its largest customer, Pengding Holdings [8] - The average selling price of strong resistance special films decreased from 3.50 yuan/square meter to 3.06 yuan/square meter over the reporting period [9] - The company anticipates a price decline of about 5% for these products in 2023 and 2024 compared to the previous periods [9]

Group 1: New IPOs - This week (September 15 to 19), there are 5 new stocks available for subscription, including 1 from the Shenzhen Main Board, 3 from the ChiNext, and 1 from the Beijing Stock Exchange [1] - The ChiNext new stock, United Power, has an issue price of 12.48 CNY per share and a price-to-earnings ratio of 32.87, compared to the industry average of 28.3 [2] - United Power is a leading enterprise in the new energy vehicle power system, operating independently within the Inovance Technology system since 2016, and plans to raise 3.601 billion CNY through its IPO [2] - Another ChiNext new stock, Jianfa Zhixin, focuses on high-value medical device distribution and plans to raise 484 million CNY [3] - The Shenzhen Main Board new stock, Ruili Kemi, specializes in active safety systems for vehicles and aims to raise funds for various projects [3] - The ChiNext new stock, Yunhan Xincheng, is an innovative high-tech enterprise in electronic component distribution, planning to raise 522 million CNY [4] Group 2: Upcoming IPO Meetings - Three companies are scheduled for IPO meetings this week: Yuxun Co. for the Sci-Tech Innovation Board, Xin Guoyi for the ChiNext, and Yuanchuang Co. for the Shenzhen Main Board [5] - Yuxun Co. is a national champion in the optical communication field, focusing on the development and sales of optical communication chips, with an IPO fundraising target of 889 million CNY [6] - Xin Guoyi specializes in high-performance specialty functional materials, aiming to raise 638 million CNY through its IPO [6] - Yuanchuang Co. is a leading player in the rubber track industry, with a significant market share and plans to raise 485 million CNY [7]